Works matching IS 03407004 AND DT 2020 AND VI 69 AND IP 6

Results: 21

Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19.

Published in:

2020

By:

Dong, Haidong

Publication type:

Editorial

Advances and perspectives of dendritic cell-based active immunotherapies in follicular lymphoma.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 913, doi. 10.1007/s00262-020-02577-w

By:

Cox, Maria Christina;
Lapenta, Caterina;
Santini, Stefano M.

Publication type:

Article

Correction to: Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors.

Published in:

2020

By:

Wu, Qing;
Liu, Junjin;
Zhang, Yanhong;
Wu, Sumei;
Xie, Xianhe

Publication type:

Correction Notice

Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1087, doi. 10.1007/s00262-020-02529-4

By:

Singh, Lata;
Singh, Mithalesh Kumar;
Rizvi, Moshahid Alam;
Bakhshi, Sameer;
Meel, Rachna;
Lomi, Neiwete;
Sen, Seema;
Kashyap, Seema

Publication type:

Article

Inhibition of IDO leads to IL-6-dependent systemic inflammation in mice when combined with photodynamic therapy.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1101, doi. 10.1007/s00262-020-02528-5

By:

Wachowska, Malgorzata;
Stachura, Joanna;
Tonecka, Katarzyna;
Fidyt, Klaudyna;
Braniewska, Agata;
Sas, Zuzanna;
Kotula, Iwona;
Rygiel, Tomasz Piotr;
Boon, Louis;
Golab, Jakub;
Muchowicz, Angelika

Publication type:

Article

Neutrophils are mediators of metastatic prostate cancer progression in bone.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1113, doi. 10.1007/s00262-020-02527-6

By:

Costanzo-Garvey, Diane L.;
Keeley, Tyler;
Case, Adam J.;
Watson, Gabrielle F.;
Alsamraae, Massar;
Yu, Yangsheng;
Su, Kaihong;
Heim, Cortney E.;
Kielian, Tammy;
Morrissey, Colm;
Frieling, Jeremy S.;
Cook, Leah M.

Publication type:

Article

ESTIMATE algorithm is not appropriate for inferring tumor purity and stromal and immune cell admixture in hematopoietic or stromal tumors.

Published in:

2020

By:

Liu, Qiang;
Fang, Yi;
Wang, Jing

Publication type:

Letter

Identification and validation of tumour microenvironment-based immune molecular subgroups for gastric cancer: immunotherapeutic implications.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1057, doi. 10.1007/s00262-020-02525-8

By:

Zhou, Yu-Jie;
Zhu, Gui-Qi;
Lu, Xiao-Fan;
Zheng, Kenneth I.;
Wang, Qi-Wen;
Chen, Jin-Nan;
Zhang, Qing-Wei;
Yan, Fang-Rong;
Li, Xiao-Bo

Publication type:

Article

Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 989, doi. 10.1007/s00262-020-02524-9

By:

Ohara, Mizuho;
Ohara, Kenzo;
Kumai, Takumi;
Ohkuri, Takayuki;
Nagato, Toshihiro;
Hirata-Nozaki, Yui;
Kosaka, Akemi;
Nagata, Marino;
Hayashi, Ryusuke;
Harabuchi, Shohei;
Yajima, Yuki;
Oikawa, Kensuke;
Harabuchi, Yasuaki;
Sumi, Yasuo;
Furukawa, Hiroyuki;
Kobayashi, Hiroya

Publication type:

Article

Myeloid-derived suppressor cells impede T cell functionality and promote Th17 differentiation in oral squamous cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1071, doi. 10.1007/s00262-020-02523-w

By:

Dar, Asif A.;
Patil, Rushikesh S.;
Pradhan, Trupti N.;
Chaukar, Devendra A.;
D'Cruz, Anil K.;
Chiplunkar, Shubhada V.

Publication type:

Article

Nivolumab in patients with metastatic renal cell carcinoma and chronic hepatitis C virus infection.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 983, doi. 10.1007/s00262-020-02521-y

By:

Tsimafeyeu, Ilya;
Gafanov, Rustem;
Protsenko, Svetlana;
Semenova, Anna;
Oganesyan, Ani;
Nurgaliyev, Nurzhan;
Krasny, Sergei;
Bondarenko, Anastasia;
Safina, Sufia;
Zakurdaeva, Kristina

Publication type:

Article

Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1001, doi. 10.1007/s00262-020-02520-z

By:

Rodriguez-Barbosa, Jose-Ignacio;
Azuma, Miyuki;
Zelinskyy, Gennadiy;
Perez-Simon, Jose-Antonio;
del Rio, Maria-Luisa

Publication type:

Article

Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1043, doi. 10.1007/s00262-020-02517-8

By:

Karstens, Karl-Frederick;
Kempski, Jan;
Giannou, Anastasios D.;
Pelczar, Penelope;
Steglich, Babett;
Steurer, Stefan;
Freiwald, Eric;
Woestemeier, Anna;
Konczalla, Leonie;
Tachezy, Michael;
Reeh, Matthias;
Bockhorn, Maximilian;
Perez, Daniel;
Mann, Oliver;
Lohse, Ansgar W.;
Roesch, Thomas;
Izbicki, Jakob R.;
Gagliani, Nicola;
Huber, Samuel

Publication type:

Article

Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 927, doi. 10.1007/s00262-020-02515-w

By:

Wu, Qing;
Liu, Junjin;
Zhang, Yanhong;
Wu, Sumei;
Xie, Xianhe

Publication type:

Article

CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 969, doi. 10.1007/s00262-020-02514-x

By:

Melo, Ashanty M.;
Conroy, Melissa J.;
Foley, Emma K.;
Dockry, Éilis;
Breen, Eamon P.;
Reynolds, John V.;
Lysaght, Joanne;
Doherty, Derek G.

Publication type:

Article

Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1131, doi. 10.1007/s00262-020-02509-8

By:

Kiyohara, Eiji;
Tanemura, Atsushi;
Nishioka, Megumi;
Yamada, Mizuho;
Tanaka, Aya;
Yokomi, Akinori;
Saito, Atsuhiro;
Sakura, Kazuma;
Nakajima, Toshihiro;
Myoui, Akira;
Sakurai, Toshiharu;
Kawakami, Yutaka;
Kaneda, Yasufumi;
Katayama, Ichiro

Publication type:

Article

miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 951, doi. 10.1007/s00262-020-02507-w

By:

Zhang, Meng;
Shi, Yanmei;
Zhang, Yujuan;
Wang, Yifan;
Alotaibi, Faizah;
Qiu, Li;
Wang, Hongmei;
Peng, Shanshan;
Liu, Yanling;
Li, Qing;
Gao, Dian;
Wang, Zhigang;
Yuan, Keng;
Dou, Fang-fang;
Koropatnick, James;
Xiong, Jianping;
Min, Weiping

Publication type:

Article

Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11–13 2018, Milan, Italy.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1141, doi. 10.1007/s00262-020-02502-1

By:

Bellone, Matteo;
Brevi, Arianna;
Bruzzì, Stefania;
Consonni, Michela;
De Santis, Francesca;
Di Lullo, Giulia;
Majorini, Maria Teresa;
Pastò, Anna;
Amadori, Alberto;
Bregni, Marco;
Di Nicola, Massimo;
Calabrò, Luana;
Ferrucci, Pier Francesco;
Proietti, Enrico;
Colombo, Mario Paolo;
Russo, Vincenzo

Publication type:

Article

Development and characterization of a novel anti-OX40 antibody for potent immune activation.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 939, doi. 10.1007/s00262-020-02501-2

By:

Kuang, Zhihui;
Jing, Hua;
Wu, Zhihai;
Wang, Jie;
Li, Yiming;
Ni, Haiqing;
Zhang, Pan;
Wu, Weiwei;
Wu, Min;
Zhou, Shuaixiang;
Qiu, Xuan;
Wu, Dongdong;
Prinz, Bianka;
Baruah, Hemanta;
Chen, Bingliang;
Yu, Michael;
Liu, Junjian

Publication type:

Article

Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1015, doi. 10.1007/s00262-020-02495-x

By:

Burke, Shannon;
Shergold, Amy;
Elder, Matthew J.;
Whitworth, Justine;
Cheng, Xing;
Jin, Hong;
Wilkinson, Robert W.;
Harper, James;
Carroll, Danielle K.

Publication type:

Article

Prostaglandin E2 in a TLR3- and 7/8-agonist-based DC maturation cocktail generates mature, cytokine-producing, migratory DCs but impairs antigen cross-presentation to CD8+ T cells.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1029, doi. 10.1007/s00262-019-02470-1

By:

Gierlich, Philipp;
Lex, Veronika;
Technau, Antje;
Keupp, Anne;
Morper, Lorenz;
Glunz, Amelie;
Sennholz, Hanno;
Rachor, Johannes;
Sauer, Sascha;
Marcu, Ana;
Grigoleit, Götz Ulrich;
Wölfl, Matthias;
Schlegel, Paul G.;
Eyrich, Matthias

Publication type:

Article